Jump to content

Topiramate

From Wikipedia
topiramate
type of chemical entity
Subclass of2,2,7,7-tetramethyltetrahydro-2H,3aH,7H-bis[1,3]dioxolo[4,5-b:4′,5′-d]pyran-3a-yl)methyl sulfamate Edit
Get useMedication Edit
Chemical formulaC₁₂H₂₁NO₈S Edit
Canonical SMILESCC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C Edit
Isomeric SMILESCC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C Edit
Active ingredient inTrokendi, Qudexy, Topamax, Topiragen Edit
World Health Organisation international non-proprietary nametopiramate Edit
Legal status (medicine)boxed warning Edit
Pregnancy categoryAustralian pregnancy category D, US pregnancy category D Edit
Get characteristicbitterness Edit
Subject has roleneuroprotective agent, anti-obesity medication, anticonvulsant agent, carbonic anhydrase inhibitor, developmental toxicant Edit

Topiramate, dem market as Topamax among oda names, be an oral medication dem primarily prescribe for de treatment of epilepsy den de prophylaxis of migraines.[1] For epilepsy, dis dey include treatment for generalized anaa focal seizures.[2] E sanso be used off-label for alcohol dependence den essential tremor.[1]

Common side effects dey include tingling, feeling tired, loss of appetite, abdominal pain, weight loss,[3] den cognitive dysfunction, such as trouble concentrating.[1][4] Serious side effects fi include suicidal ideation, increased ammonia levels wey dey result in encephalopathy, den kidney stones.[1] Topiramate fi cause birth defects, wey dey include cleft lip den palate.[5] Risks den benefits for be carefully discussed plus de full treatment team. Topiramate be considered "probably compatible" plus lactation wey e no be contraindicated for breastfeeding, though monitoring of de infant for diarrhea anaa poor weight gain fi be considered.[6][7] Ein mechanism of action be unclear.[1]

Na topiramate first be synthesized insyd a search for an oral hypoglycemic agent; however, na e receive ein initial approval as an anticonvulsant insyd 1996.[1] E be available as a generic medication.[4][8][9] Insyd 2023, na e be de 71st most commonly prescribed medication insyd de United States, plus more dan 9 million prescriptions.[10][11]

References

[edit | edit source]
  1. 1 2 3 4 5 6 "Topiramate Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Archived from the original on 6 March 2019. Retrieved 5 March 2019.
  2. ↑ British national formulary: BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 328. ISBN 978-0-85711-338-2.
  3. ↑ "Topiramate Side Effects: Common, Severe, Long Term". Drugs.com. Archived from the original on 10 April 2021. Retrieved 3 August 2021.
  4. 1 2 British national formulary: BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 328. ISBN 978-0-85711-338-2.
  5. ↑ "FDA Drug Safety Communication: Risk of oral clefts in children born to mothers taking Topamax (topiramate)". FDA. 18 June 2019.
  6. ↑ "Essential Reads: Breastfeeding and Anti-Epileptic Drugs". MGH Center for Women's Mental Health. 10 August 2022. Retrieved 27 December 2023.
  7. ↑ "Topiramate". Drugs and Lactation Database (LactMed®). Bethesda (MD): National Institute of Child Health and Human Development. 2006. PMID 30000318. Retrieved 27 December 2023.
  8. ↑ "Competitive Generic Therapy Approvals". U.S. Food and Drug Administration (FDA). 29 June 2023. Archived from the original on 29 June 2023. Retrieved 29 June 2023.
  9. ↑ "First Generic Drug Approvals 2023". U.S. Food and Drug Administration (FDA). 30 May 2023. Archived from the original on 30 June 2023. Retrieved 30 June 2023.
  10. ↑ "Top 300 of 2023". ClinCalc. Archived from the original on 12 August 2025. Retrieved 12 August 2025.
  11. ↑ "Topiramate Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 18 August 2025.
[edit | edit source]